Clinical Trials Browser

Phase 2 × Active not recruiting × aflutinib × Clear all

NCT05466149 2025-11-19

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Phase 2 Active not recruiting

NSCLC